Papers, abstracts, presentations, posters and webcasts emanating from the audit
EASD Lisbon 2017: AN Lumb, RD Rea, RR Abraham, P Macdonald, SC Bain, REJ Ryder on behalf of the ABCD nationwide degludec audit contributors. Effect of insulin degludec on HbA1c, weight and hypoglycaemia: data from the Association of British Clinical Diabetologists (ABCD) nationwide degludec audit
ABCD Spring Meeting, London 2016: A Lumb, R Abraham, R Harper, SC Bain, R Rea, REJ Ryder, on behalf of the ABCD nationwide degludec audit contributors. Insulin degludec improves minor, severe and nocturnal hypoglycaemia in Type 1 diabetes: Association of British Clinical Diabetologists (ABCD) nationwide insulin degludec audit.
DUK Manchester 2017: AN Lumb, RD Rea, R Abraham, P McDonald, SC Bain and REJ Ryder. Effect on HbA1c of switching to insulin degludec from another basal insulin: the Association of British Clinical Diabetologists (ABCD) nationwide degludec audit. Diabetic Medicine 2017. 34 (Suppl 1): Abstract P182
EASD Lisbon 2017: AN Lumb, RD Rea, RR Abraham, P Macdonald, SC Bain, REJ Ryder on behalf of the ABCD nationwide degludec audit contributors. Effect of insulin degludec on HbA1c, weight and hypoglycaemia: data from the Association of British Clinical Diabetologists (ABCD) nationwide degludec audit. Diabetologia 2017, Vol.60 Supplement1: Abstract 669
ADA Orlando 2018: AN. Lumb, Ian W. Gallen, A Bickerton, RR. Abraham, SC. Bain, R Harper, RE Ryder and ABCD Nationwide Degludec Audit Contributors. Use of Insulin Degludec in Type 1 Diabetes Clinical Practice in the U.K.—General Practice Data from Two English Regions and Data from the Association of British Clinical Diabetologists (ABCD) Nationwide Degludec Audit. Diabetes 2018 Jul; 67 (Supplement 1): 2291-PUB.
The ABCD nationwide insulin degludec audit is an independent audit supported by an unrestricted grant from Novo Nordisk
